Results 41 to 50 of about 7,978,447 (307)

Heterogeneous plaque–lumen geometry is associated with major adverse cardiovascular events

open access: yesEuropean Heart Journal Open, 2023
Abstract Aims Prospective studies show that only a minority of plaques with higher risk features develop future major adverse cardiovascular events (MACE), indicating the need for more predictive markers.
Gu, Sophie Z   +10 more
openaire   +2 more sources

Major Adverse Cardiovascular Events and Mortality in Systemic Lupus Erythematosus Patients After Successful Delivery: A Population-based Study

open access: yes, 2017
Background:Limited data exist regarding the incidence rate and hazard ratios (HRs) of major adverse cardiovascular events and mortality in the successful-delivery women with or without systemic lupus erythematosus.Methods:A retrospective, population ...
Wu, Lung-Sheng;Tang, Chao-Hsiun;Lin, Yu-Sheng;Lin, Chia-Pin;Hung, Sheng-Tzu;Hwa, Hsiao-Lin;Luo, Shue-Fen;Chu, Pao-Hsien   +1 more
core   +1 more source

Pyoderma Gangrenosum Associated With Major Adverse Cardiovascular Events

open access: yesJEADV Clinical Practice
ABSTRACT Background Pyoderma gangrenosum (PG) is a neutrophilic dermatosis characterized by the rapid onset of painful ulcers. Previous retrospective population‐based studies have identified a relationship between PG and major adverse cardiovascular events (MACE).
Nana Ama Adjei‐Frimpong   +3 more
openaire   +3 more sources

Major Adverse Cardiovascular Event free survival curves of neutrophil to lymphocyte ratio (NLR) risk groups estimated by the Kaplan-Meier method.

open access: yes, 2016
Major Adverse Cardiovascular Event free survival curves of neutrophil to lymphocyte ratio (NLR) risk groups estimated by the Kaplan-Meier method.
Ae-Young Her (775370)   +4 more
core   +1 more source

Effectiveness of PCSK9 inhibitors versus statins in type 2 diabetes and dyslipidemia: a propensity-matched study

open access: yesFrontiers in Endocrinology
BackgroundProprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9is) exhibit promising lipid-lowering activity, but evidence regarding their effectiveness in real-world diabetic populations is limited.MethodsBased on TriNetX database, individuals
Jheng-Yan Wu   +10 more
doaj   +1 more source

Kaplan–Meier plots, with 95% confidence intervals, for time to first major adverse cardiovascular event by diabetes cohort and nearest proteinuria category prior to event.

open access: yes, 2019
a. Type 1 diabetes, b. Type 2 diabetes, c. Non-diabetes, d. Overall MACE, major adverse cardiovascular event. * Index date defined as the earlier of the patient’s first abnormal eGFR or, if available, first abnormal proteinuria record.
Thomas R. Berni (7321634)   +7 more
core   +1 more source

Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer [PDF]

open access: yes, 2007
Background Selective cyclooxygenase inhibitors may retard the progression of cancer, but they have enhanced thrombotic potential. We report on cardiovascular adverse events in patients receiving rofecoxib to reduce rates of recurrence of colorectal ...
Christopher C. McConkey   +23 more
core   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani   +7 more
wiley   +1 more source

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo   +5 more
wiley   +1 more source

Mortality and cardiorenal outcomes among heart failure patients with zinc deficiency: a multicenter retrospective cohort study of 8,290 patients

open access: yesFrontiers in Nutrition
ObjectiveThis study aimed to examine the association between zinc deficiency (ZD) and the clinical outcomes in patients with heart failure (HF).MethodsThis multicenter retrospective cohort study used the TriNetX network to identify adult patients with HF
Yu-Min Lin   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy